Abuja - The Economic Community of West African States (ECOWAS) has begun initiatives towards the construction of a factory aimed at intensifying the fight against malaria.
The factory, which will built in Ghana, will produce biolarvicide, the drug that is prominent in malaria treatment.
A ground-breaking ceremony has been held ahead of the construction of the factory.
According to a press statement released by the regional body in Abuja, the programme is being held within the framework of the Campaign for the Elimination of Malaria in West Africa by 2015.
This brings together health experts from within and outside the ECOWAS region.
The Accra factory is one of the three being constructed in the region under a tripartite agreement involving ECOWAS, Cuba and Venezuela.
The regional campaign seeks to free the region from the malaria scourge that kills thousands of people in Africa a year and costs the continent more than US$12 billion annually.
The regional campaign is focused on the strengthening of the vector control component, recognised internationally as the only intervention that can reduce malaria transmission from high level to zero.
Cuba and Venezuela are providing the financial support, technical know-how and technology transfer to make readily available in the region, biolarvicide, the substance that destroys mosquitoes, the malaria vectors in their larvae stage of development.
Similar campaigns have yielded resounding successes in Latin America and other parts of the world.
Participants will discuss among others, the feasibility study, cost build up and investment architecture of the project as well as the forthcoming 4th High-Level partners meeting in Venezuela.
Malaria is not only a major public health problem in Africa, with West Africa bearing the heaviest burden.
It also stunts the economic development of the region and the continent as a whole.
- CAJ News